Found: 96
Select item for more details and to access through your institution.
Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 634, doi. 10.3390/cells8060634
- By:
- Publication type:
- Article
IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 3, p. 285, doi. 10.3390/cells8030285
- By:
- Publication type:
- Article
The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Extended interval dosing with ocrelizumab in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 847, doi. 10.1177/13524585241245296
- By:
- Publication type:
- Article
Torben Fog – A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 623, doi. 10.1177/13524585241239506
- By:
- Publication type:
- Article
Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in Denmark.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 184, doi. 10.1177/13524585231221415
- By:
- Publication type:
- Article
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 103, doi. 10.1177/13524585231214362
- By:
- Publication type:
- Article
Extended dosing of monoclonal antibodies in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2001, doi. 10.1177/13524585211065711
- By:
- Publication type:
- Article
All anti-CD20 monoclonal antibodies have similar efficacy and risks: No.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1845, doi. 10.1177/13524585221103729
- By:
- Publication type:
- Article
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 9, p. 1340, doi. 10.1177/13524585211067696
- By:
- Publication type:
- Article
Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1239, doi. 10.1177/13524585211057767
- By:
- Publication type:
- Article
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2254, doi. 10.1177/13524585211003291
- By:
- Publication type:
- Article
Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 2, p. 188, doi. 10.1177/1352458520912500
- By:
- Publication type:
- Article
Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1572, doi. 10.1177/1352458518795418
- By:
- Publication type:
- Article
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 11, p. 1444, doi. 10.1177/1352458518794308
- By:
- Publication type:
- Article
Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 9, p. 1298, doi. 10.1177/1352458518791753
- By:
- Publication type:
- Article
Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 9, p. 1289, doi. 10.1177/1352458518790417
- By:
- Publication type:
- Article
CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 7, p. 937, doi. 10.1177/1352458518774880
- By:
- Publication type:
- Article
Prediction of natalizumab anti-drug antibodies persistency.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 3, p. 392, doi. 10.1177/1352458517753721
- By:
- Publication type:
- Article
Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202530
- By:
- Publication type:
- Article
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
- Published in:
- Journal of Neuroinflammation, 2012, v. 9, n. 1, p. 215, doi. 10.1186/1742-2094-9-215
- By:
- Publication type:
- Article
Defining active progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1727, doi. 10.1177/1352458517726592
- By:
- Publication type:
- Article
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 675, doi. 10.1177/1352458516661048
- By:
- Publication type:
- Article
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 2, p. 234, doi. 10.1177/1352458516643393
- By:
- Publication type:
- Article
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 1, p. 94, doi. 10.1177/1352458516638941
- By:
- Publication type:
- Article
Neurofilament in CSF—A biomarker of disease activity and long-term prognosis in multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 926, doi. 10.1177/1352458515605908
- By:
- Publication type:
- Article
Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 11, p. 1414, doi. 10.1177/1352458514563590
- By:
- Publication type:
- Article
Differential microRNA expression in blood in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 14, p. 1849, doi. 10.1177/1352458513490542
- By:
- Publication type:
- Article
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 9, p. 1226, doi. 10.1177/1352458513481010
- By:
- Publication type:
- Article
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 7, p. 877, doi. 10.1177/1352458512466929
- By:
- Publication type:
- Article
Prediction of antibody persistency from antibody titres to natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 10, p. 1493, doi. 10.1177/1352458512441688
- By:
- Publication type:
- Article
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 9, p. 1074, doi. 10.1177/1352458511404271
- By:
- Publication type:
- Article
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 5, p. 567, doi. 10.1177/1352458510393771
- By:
- Publication type:
- Article
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 3, p. 335, doi. 10.1177/1352458510389102
- By:
- Publication type:
- Article
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 1, p. 32, doi. 10.1177/1352458510382247
- By:
- Publication type:
- Article
Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 3, p. 518, doi. 10.1002/ana.26684
- By:
- Publication type:
- Article
Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration.
- Published in:
- Immunity & Ageing, 2019, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12979-019-0160-0
- By:
- Publication type:
- Article
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211053939
- By:
- Publication type:
- Article
Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211053939
- By:
- Publication type:
- Article
Progressive multiple sclerosis, cognitive function, and quality of life.
- Published in:
- Brain & Behavior, 2018, v. 8, n. 2, p. 1, doi. 10.1002/brb3.875
- By:
- Publication type:
- Article
The gut microbiota in multiple sclerosis varies with disease activity.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-022-01148-1
- By:
- Publication type:
- Article
Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655.
- Published in:
- European Journal of Human Genetics, 2011, v. 19, n. 10, p. 1100, doi. 10.1038/ejhg.2011.88
- By:
- Publication type:
- Article
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis.
- Published in:
- European Journal of Human Genetics, 2010, v. 18, n. 4, p. 502, doi. 10.1038/ejhg.2009.195
- By:
- Publication type:
- Article